糖皮质激素对慢性肾脏疾病患者骨代谢影响的机制及对策
被引量:6
摘要
在风湿免疫性疾病及器官移植领域,糖皮质激素(GC)应用日益广泛。继绝经后妇女及老年性骨质疏松后,GC诱导的骨质疏松(GIOP)已经成为骨质疏松第三大原因。除了直接减少成骨细胞的数量和活性外,GC还可降低钙在胃肠道的吸收,加速。肾脏钙的排泄,并通过减少性激素分泌、抑制胰岛素样生长因子和前列腺素E2产生以及影响甲状旁腺激素(PTH)等环节导致骨量减少。
出处
《中华肾脏病杂志》
CAS
CSCD
北大核心
2010年第3期229-232,共4页
Chinese Journal of Nephrology
参考文献26
-
1Adachi JD.Glucocorticoid-induced osteoporosis.Osteoporos Int,2009,20:S239-S240.
-
2Khosla S,Lufkin EC,Hodgson SF.Epidemiology and clinical features of osteoporosis in young individuals.Bone,1994,15:551-555.
-
3Van Staa TP,Leufkens HG,Cooper C,et al.The epidemiology of corticosteroid-induced osteoporosis:a meta-analysis.Osteoporos Int,2002,13:777-787.
-
4Biyikli NK,Emre S,Sirin A,et al.Biochemical bone markers in nephrotic children.Pediatr Nephrol,2004,19:869-873.
-
5Jalanko H.Congenital nephrotic syndrome.Pediatr Nephrol,2009,24:2121-2128.
-
6Kano K,Yamada Y,Nishikura K,et al.Low bone mineral density in nephrotic children with steroid dependence and/or frequent relapsers.Clin Nephrol,2005,64:323-234.
-
7Elder GJ.Nephrotic syndrome:don't forget the bones! Nephrology,2008,13:43-44.
-
8Levin A,Bakris GL,Molitch M,et al.Prevalence of abnormal serum vitamin D,PTH,calcium,and phosphorus in patients with chronic kidney disease:results of the study to evaluate early kidney disease.Kidney Int,2007,71:31-38.
-
9Van staa TP,Leufkens HC,Abenhaim L,et al.Oral corticosteroids and fracture risk:relationship to daily and cumulative doses.Rheumatology,2000,39:1383-1389.
-
10Delany AM,Durant D,Canalis E.Glucocorticoid supperssion of IGF-1 transcription in osteoblasts.Mol Endocrinol,2001,15:1781-1789.
二级参考文献5
-
1李寒,王沛,刘升云,刘章锁.伊班膦酸钠注射液治疗糖皮质激素引起的骨质疏松症的临床研究[J].中国现代医学杂志,2004,14(23):24-27. 被引量:1
-
2Fujita T, Satomura A, Hidaka M, et al. Acute alteration in bone mineral density and biochemical markers for bone metabolism in nephritic patients receiving high - dose glucocorticoid and one-cycle etidronate therapy. Calcif Tissue Int, 2000, 66:195-199.
-
3McKenzie R, Reynolds JC, O'Fallon A, et al. Decresed bone mineral during low dose glucocorticoid administration in a randomised-placebo controlled trial. J Rheumatol, 2000,27: 2222-2225.
-
4Adachi J, Bensen WG, Brown J, et al. Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis. N Engl J Med, 1997, 337: 382-387.
-
5Gulati S, Godbole M, Singh U, et al. Are children with idiopathic nephrotic syndrome at risk for metabolic bone disease. Am J Kidney Dis, 2003,41:1163-1169.
共引文献8
-
1陈越(综述),钟一红(审校),丁小强(审校).糖皮质激素性骨质疏松的药物防治[J].国际泌尿系统杂志,2007,27(3):399-402. 被引量:1
-
2陈航,高燕,贾海红,张金超,孙静,李美朝.肾病综合征患者停用糖皮质激素后骨质疏松恢复情况[J].中国现代医学杂志,2009,19(19):2989-2990. 被引量:1
-
3亢泽坤,张坤娟,张剑,范树成,张缘媛,肖建,何飞,李彦君,刘东刚.伊班膦酸钠治疗糖皮质激素诱导的家兔骨质疏松症[J].中国新药杂志,2011,20(12):1131-1135.
-
4黄松,冯栋.伊班膦酸钠联合治疗类固醇性骨质疏松症26例临床观察[J].中国实用医药,2011,6(20):7-8. 被引量:2
-
5杨海娟,高丛斌,宋芬.全程护理干预对原发性肾病综合征糖皮质激素性骨质疏松的影响研究[J].当代护士(中旬刊),2012,19(4):1-3. 被引量:5
-
6杨先凯,卜林,卢志芳.原发性肾小球疾病患者应用糖皮质激素期间监测骨密度的价值[J].现代中西医结合杂志,2012,21(28):3112-3113. 被引量:1
-
7张莉莉,李立东,洪小丽,郭宗晓.我国人群全身应用糖皮质激素致骨质疏松患病率的Meta分析[J].现代预防医学,2022,49(12):2298-2304. 被引量:4
-
8赵新兰,秦爱平,陈凯,李浪波.伊班膦酸钠和辛伐他汀联合治疗老年性骨质疏松症的临床疗效[J].中国保健营养(下半月),2013,0(5):1400-1400.
同被引文献59
-
1张群慧,倪丽.风湿免疫疾病中肺部并发症预防及护理[J].实用医技杂志,2008,15(33). 被引量:10
-
2陈运生,王德,孙玲玲,陈月生,赵维玲,马祖祥.原发性肾病综合征患儿血清IGF-Ⅰ和血脂变化及相关性研究[J].蚌埠医学院学报,2006,31(4):426-428. 被引量:5
-
3Ortoft G,Andreassen TT,Oxlund H.Growth hormone can reverse glucocorticoid-induced low bone turnover on cortical but not on cancellous bone surfaces in adult Wistar rats.Bone,2005,36:123-133.
-
4Kim HJ.New understanding of glucocorticoid action in bone cells.BMB Rep,2010,43:524-529.
-
5Weinstein RS,Chen JR,Powers CC,et al.Promoting of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids.J Clin Invest,2002,109:1041-1048.
-
6Angeli A,Guglielmi G,Dovio A,et al.High prevalence of asymptomatic vertebral fractures in post-menopausal women receiving chronic glucocorticoid therapy:a cross-sectional outpatient study.Bone,2006,39:253-259.
-
7Pennisi P,Trombetti A,Rizzoli R.Glucocorticoid-induced osteoporosis and its treatment.Clin Orthop Relat Res,2006,443:39-47.
-
8Van Staa TP,Cooper C,Leufkens HG,et al.Children and the risk of fractures caused by oral corticosteroids.J Bone Miner Res,2003,18:913-918.
-
9Macrae VE,Ahmed SF,Mushtaq T,et al.IGF-1 signalling in bone growth:inhibitory actions of dexamethasone and IL1beta.Growth Horm IGF Res,2007,17:435-439.
-
10Celiker R,Arslan S.Comparison of serum insulin-like growth factor-1 and growth hormone levels in osteoporotic and non-osteoporotic post-menopausal women.Rheumatol Int,2000,19:205-208.
引证文献6
-
1王玲,袁伟杰,谷立杰,尚明花.糖皮质激素诱导胰岛素样生长因子1降低对原发性肾病综合征患者骨代谢的影响[J].中华肾脏病杂志,2011,27(2):82-86. 被引量:11
-
2林岩.慢性肾脏病患者糖皮质激素性骨质疏松的诊治进展[J].吉林医药学院学报,2015,36(3):209-212. 被引量:1
-
3关翠嫦,谭秀红,陈彩霞.慢性肾脏疾病患者甲状旁腺激素水平对肾性贫血的影响观察[J].岭南急诊医学杂志,2015,20(4):335-336. 被引量:2
-
4唐兰.风湿免疫疾病中肺部并发症的治疗与护理[J].实用临床医药杂志,2016,20(6):29-31. 被引量:17
-
5张文娟,张国晋,王丹,陈克明,周俊林.基于能谱CT基物质成像技术的骨密度测量[J].中国医学影像学杂志,2017,25(2):121-124. 被引量:22
-
6黄春琳.胰岛素样生长因子1和肾脏疾病的相关性研究[J].中国医药指南,2018,16(34):24-25. 被引量:3
二级引证文献56
-
1孙俊杰.优质护理服务在风湿疼痛感护理中的临床应用[J].世界最新医学信息文摘,2020(39):229-229.
-
2王嘉琳,袁伟杰.慢性肾脏病诱导骨骼肌萎缩的发病机制[J].肾脏病与透析肾移植杂志,2013,22(2):158-161. 被引量:2
-
3李敏豪.哮喘患儿骨密度、骨代谢及肾上腺皮质功能的糖皮质激素吸入治疗影响探讨[J].医学理论与实践,2013,26(15):2018-2019. 被引量:1
-
4许喜闻.哮喘患儿长期吸入小剂量布地奈得对骨密度影响的探讨[J].江西医药,2014,49(6):533-534. 被引量:2
-
5郝万庆,朱蓉蓉,张蕾,高永斌,刘刚,哈若水.磁共振脂肪定量扫描测量绝经后妇女腰椎脂肪含量与骨密度的相关性研究[J].宁夏医学杂志,2019,41(1):33-35. 被引量:6
-
6黄雄亮.归脾汤治疗肾性贫血临床研究[J].新中医,2019,51(1):66-70. 被引量:11
-
7王玲,袁伟杰.慢性肾脏病患者蛋白-能量消耗发生机制及干预的研究进展[J].中华肾病研究电子杂志,2014,3(4):41-45. 被引量:6
-
8范光磊,栾玉芬,彭鸣亚,方莉,何雪晴,徐龙宝.骨转换生化指标与原发性肾病综合征并发肾性骨营养不良的相关性研究[J].中华核医学与分子影像杂志,2015,35(1):44-47. 被引量:3
-
9方莉,范光磊.骨转换生化标志物在原发性肾病综合征肾性骨营养不良诊断中的价值[J].实用临床医学(江西),2015,16(3):4-6. 被引量:1
-
10高庆祥.奥扎格雷钠联合低分子肝素钙在治疗短暂性脑缺血发作中的临床疗效[J].中国卫生标准管理,2017,8(3):79-80. 被引量:5
-
1耿洁,叶霜,鲍春德.风湿免疫性疾病继发脊柱感染四例临床分析[J].中华临床免疫和变态反应杂志,2009,3(4):278-280. 被引量:2
-
2龙玲.“风湿免疫性疾病的诊疗与新进展学习班”在广西南宁市成功举办[J].内科,2009,4(4):510-510.
-
3廖平川,康俊萍,孔祥东,刘秀峰,刘玛梅,马双全.小腿肿胀的超声检查与鉴别诊断[J].中国药物与临床,2013,13(1):60-62.
-
4陈会芳.综合疗法治疗强直性脊柱炎的疗效观察[J].中国民族民间医药,2010,19(6):148-148. 被引量:5
-
5郭潇潇,吴庆军,曾小峰,张奉春,唐福林.原发性干燥综合征继发淀粉样变三例[J].中华风湿病学杂志,2006,10(5):315-316. 被引量:8
-
6医讯[J].中国家庭医生,2010(16):3-3.
-
7王晓红.风湿免疫性疾病治疗的研究进展[J].器官移植内科学杂志,2015,10(1):25-38. 被引量:2
-
8邓波.使用环磷酰胺治疗系统性红斑狼疮的体会——附1例病例报告[J].四川省卫生管理干部学院学报,2009,28(2):171-173. 被引量:1
-
9包佐义.前列腺增生如何预防尿潴留[J].家庭医学(上半月),2004(15):18-18.
-
10赵志权,霍冬梅,磨红.阿法骨化醇与碳酸钙对慢性肾衰患者骨代谢影响的对比研究[J].广西医科大学学报,2004,21(6):838-840. 被引量:2